IInformation from the US is growing concern in the international science and medicine community. After the US withdrawal from the World Health Organization (WHO), the budget freezes for major US public health research institutes, the suspension of the US International Development Organization (USAID) Development Assistance Program, and was created in 2003 by George W. Bush. The restrictions placed on the President's Emergency Plan for AIDS Relief (PEPFAR) have put a serious threat to cooperation between researchers and scientific advances. Additionally, censorship is a key topic such as the fundamental principles of equity, diversity, and inclusion, or the climate crisis that has now been removed from official US texts.
In this context, the French National Research Agency's scientific community on AIDS, viral hepatitis and emerging infectious diseases (ANRS MIE), an agency of the French National Institute of Health and Medicine (INSERM), has expressed solidarity with Americans. It's there. With everyone involved and everyone involved. He also expressed deep concern about the possible outcomes of this unprecedented global health situation.
The international collaboration, as Peter Abu (2003 Nobel Prize in Chemistry), emphasizes, is “not only essential for scientific advancement, but also for the future of humanity.” No matter how strong it is, there is no country for today's global challenges. These collaborations have achieved substantial results in both the acquisition of new knowledge and improvement in public health, as well as countries with the richest and intermediate resources, particularly in the areas of HIV/AIDS and infectious diseases.
Pandemic risk
The United States is a major player in funding for scientific research. The National Institutes of Health (NIH), a US government agency responsible for biomedical research, had $3.3 billion in 2023 on the sole topic of HIV/AIDS. of a privileged French partner. By joining the military, American researchers and French teams at ANRS MIE made great advances, including demonstrating the effectiveness of antiretroviral prevention in maternal transmission of HIV, particularly antituberculosis treatment in patients with HIV. I've done it. Recently, pre-exposure prevention (PREP) to prevent HIV infection.
54.6% of this article remains to read. The rest is only for subscribers.
